CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

UCB plans interim FASTRAX study findings on patient-initiated axSpA care at ACR 2026

By Public Technologies
  • UCB will present 18 accepted abstracts on rheumatic diseases at the American College of Rheumatology congress in 2026.
  • Interim FASTRAX findings will evaluate patient outcomes and experiences across standard care and patient-initiated follow-up for axial spondyloarthritis.
  • The digital platform lets clinically stable patients monitor symptoms at home and seek support when needed, aiming to improve service efficiency.
  • Research will also cover the first application of TRM-SLE, a lupus treatment-response measure designed to complement existing measures; further validation is needed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UCB SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk